CARE Ratings Ltd
CARE Ratings Ltd
Financial ServicesKey Fundamentals
MicrocapRating ServicesFinancial ServicesInsights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view CARE Ratings Ltd insights
37 extracted metrics + investor summaries across FY13–FY26.
Tapetide Score
Data-driven rating, 0–100. How it works →
Technical Indicators
Key Insights
Strengths
2- Company is almost debt free.
- Company has been maintaining a healthy dividend payout of 43.8%
Growth Rate
AI Analysis — Bull vs Bear
CARE Ratings Ltd is India's second-largest credit rating agency with approximately 29% market share, trading at a market cap of ₹5,152 crore and a PE of 29.6x. The company is virtually debt-free with a 3-year profit CAGR of 27% and ROE of 20%, though it trades at a premium valuation of 5.5x book value with no identified promoter holding.
- Debt-free balance sheet provides financial resilience with negligible leverage, eliminating interest cost drag on profitability
- Strong 3-year compounded profit growth of 27% demonstrates sustained earnings momentum well above its 10-year CAGR of 4%
- ROE of 20% in the last year (18% 3-year average) indicates efficient capital deployment in an asset-light business model
- Revenue growth of 18% TTM and 19% over 3 years shows consistent top-line expansion driven by India's growing credit market
- Healthy dividend payout of 43.8% with a current yield of 1.29% offers tangible cash returns to shareholders
- PE of 29.6x trades at a significant discount to market leader CRISIL at approximately 37x, despite similar business characteristics
- Oligopolistic industry structure with only 6-7 SEBI-registered rating agencies creates high barriers to entry and pricing power
- FY25 consolidated revenue reached approximately ₹402 crore, up 21% year-on-year, reflecting strong demand for credit ratings amid rising bond issuances
- No identifiable promoter holding (0%) leaves the company without a strategic anchor investor, potentially increasing vulnerability to activist or hostile actions
- Price-to-book ratio of 5.51x is elevated for a financial services firm, limiting margin of safety if growth decelerates
- 10-year compounded sales CAGR of only 5% and profit CAGR of 4% indicate that recent strong growth may be cyclical rather than structural
- Stock CAGR of just 1% over the past 1 year and 5% over 10 years suggests extended periods of poor price performance despite business growth
- Distant second to CRISIL which commands approximately 65% market share, limiting pricing power and ability to win mandates from top-tier corporates
- FII holding at around 23-24% means significant foreign ownership that can create selling pressure during emerging market risk-off events
- Credit rating is a cyclical business tied to debt issuance volumes; any slowdown in India's capex cycle or bond market could compress revenues
- Retail and public shareholders hold approximately 45% of shares, creating potential overhang from fragmented ownership with no committed long-term anchor
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
- Strong dividend payout confirmed Jul 3
CARE Ratings approved total dividend of ₹22 per share (₹8 interim + ₹14 final) at its 33rd AGM on July 3, 2026, signaling healthy cash generation and shareholder returns.
TL;DR: CARE Ratings is returning meaningful capital to shareholders with a ₹22/share total dividend, reflecting solid profitability in the credit rating business. No headwinds or risks surfaced in the current news cycle. The dividend approval suggests management confidence in sustained earnings, though limited news flow makes it difficult to assess broader trend direction.
Quarterly Results
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 66 | 96 | 79 | 90 | 79 | 117 | 96 | 110 | 94 | 136 | 112 | 131 | 112 |
| Expenses | 49 | 55 | 55 | 61 | 57 | 62 | 66 | 62 | 66 | 68 | 72 | 70 | 77 |
| Operating Profit | 18 | 42 | 23 | 29 | 22 | 56 | 30 | 47 | 28 | 68 | 40 | 61 | 35 |
| OPM % | 27% | 43% | 30% | 32% | 28% | 47% | 32% | 43% | 30% | 50% | 36% | 46% | 31% |
| Other Income | 12 | 11 | 14 | 10 | 12 | 12 | 12 | 15 | 14 | 13 | 13 | 16 | 15 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 4 |
| PBT | 26 | 50 | 34 | 36 | 30 | 64 | 39 | 59 | 37 | 77 | 49 | 72 | 45 |
| Tax % | 31% | 29% | 30% | 32% | 30% | 27% | 27% | 26% | 29% | 26% | 25% | 26% | 27% |
| Net Profit | 18 | 36 | 24 | 25 | 21 | 47 | 28 | 43 | 26 | 57 | 37 | 53 | 33 |
| EPS in Rs | 5.99 | 11.81 | 7.88 | 8.07 | 6.94 | 15.41 | 9.29 | 14.24 | 8.61 | 18.89 | 11.96 | 17.58 | 10.73 |
Profit & Loss
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 261 | 279 | 287 | 333 | 319 | 244 | 248 | 248 | 279 | 332 | 402 | 473 | 491 |
| Expenses | 101 | 105 | 105 | 122 | 144 | 162 | 153 | 168 | 180 | 220 | 247 | 276 | 287 |
| Operating Profit | 160 | 174 | 182 | 211 | 175 | 81 | 96 | 80 | 99 | 112 | 155 | 197 | 204 |
| OPM % | 61% | 62% | 63% | 63% | 55% | 33% | 39% | 32% | 36% | 34% | 39% | 42% | 42% |
| Other Income | 44 | 9 | 34 | 25 | 30 | 31 | 31 | 27 | 38 | 47 | 51 | 55 | 56 |
| Interest | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 2 | 2 | 2 | 2 |
| Depreciation | 5 | 4 | 3 | 3 | 3 | 8 | 8 | 8 | 11 | 10 | 12 | 14 | 15 |
| PBT | 197 | 178 | 212 | 233 | 202 | 104 | 119 | 99 | 126 | 147 | 192 | 235 | 243 |
| Tax % | 30% | 33% | 31% | 30% | 32% | 20% | 23% | 22% | 32% | 30% | 27% | 26% | — |
| Net Profit | 138 | 120 | 148 | 162 | 138 | 83 | 91 | 77 | 85 | 103 | 140 | 174 | 180 |
| EPS in Rs | 47.53 | 40.68 | 50.13 | 55.13 | 46.66 | 27.96 | 30.39 | 25.34 | 28.12 | 33.67 | 45.85 | 56.97 | 59.16 |
| Div. Payout % | 166% | 69% | 56% | 100% | 64% | 70% | 56% | 67% | 89% | 53% | 39% | 39% | — |
Balance Sheet
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 29 | 29 | 29 | 29 | 29 | 29 | 29 | 30 | 30 | 30 | 30 | 30 |
| Reserves | 330 | 379 | 491 | 567 | 521 | 504 | 559 | 618 | 643 | 687 | 776 | 902 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 7 | 9 | 17 | 20 | 24 | 26 |
| Other Liabilities | 87 | 94 | 64 | 61 | 64 | 85 | 74 | 69 | 80 | 105 | 128 | 146 |
| Total Liabilities | 446 | 502 | 584 | 658 | 614 | 618 | 671 | 725 | 770 | 842 | 958 | 1,105 |
| Fixed Assets | 65 | 64 | 61 | 60 | 83 | 93 | 85 | 96 | 107 | 109 | 119 | 122 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 1 | 3 | 8 | 4 | 6 | 3 | 5 |
| Investments | 335 | 381 | 466 | 518 | 439 | 339 | 240 | 44 | 44 | 44 | 134 | 87 |
| Other Assets | 46 | 58 | 57 | 79 | 93 | 185 | 343 | 577 | 614 | 683 | 702 | 890 |
| Total Assets | 446 | 502 | 584 | 658 | 614 | 618 | 671 | 725 | 770 | 842 | 958 | 1,105 |
Cash Flow
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 107 | 106 | 119 | 134 | 109 | 67 | 86 | 68 | 82 | 91 | 123 | 148 |
| Investing | 157 | -41 | -22 | -25 | 83 | 27 | -38 | -27 | 13 | -39 | -58 | -94 |
| Financing | -276 | -66 | -96 | -99 | -195 | -107 | -43 | -35 | -63 | -63 | -54 | -59 |
| Net Cash Flow | -12 | -1 | 1 | 11 | -4 | -13 | 5 | 6 | 32 | -11 | 11 | -6 |
| Free Cash Flow | 96 | 104 | 118 | 131 | 82 | 63 | 82 | 49 | 71 | 82 | 108 | 140 |
| CFO/OP | 104 | 95 | 101 | 95 | 98 | 125 | 114 | 122 | 115 | 119 | 112 | 107 |
Ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 22 | 31 | 32 | 43 | 54 | 61 | 31 | 25 | 27 | 25 | 29 | 27 |
| Cash Conversion Cycle | 22 | 31 | 32 | 43 | 54 | 61 | 31 | 25 | 27 | 25 | 29 | 27 |
| Working Capital Days | -82 | -65 | -10 | -1 | 13 | 14 | -3 | 635 | 638 | 591 | 451 | 316 |
| ROCE % | 39% | 46% | 44% | 41% | 35% | 19% | 21% | 16% | 19% | 21% | 25% | 26% |
Documents
Frequently Asked Questions about CARE Ratings Ltd
What does CARE Ratings Ltd do?
Where is CARE Ratings Ltd (CARERATING) listed?
Which sector does CARE Ratings Ltd belong to?
What is the market capitalisation of CARE Ratings Ltd?
What is the PE ratio of CARE Ratings Ltd?
What is the 52-week high and low of CARE Ratings Ltd?
Does CARE Ratings Ltd pay dividends?
What is the Return on Equity (ROE) of CARE Ratings Ltd?
How can I research CARE Ratings Ltd on Tapetide?
Company Information
CARE Ratings is a leading credit rating agency of India. The Company provides various credit ratings that helps corporates to raise capital for their various requirements and assists the investors to form an informed investment decision based on the credit risk and their own riskreturn expectations.(Source : 202003-01 Annual Report Page No:134)